Jenburkt Pharmaceuticals Ltd
BSE:524731

Watchlist Manager
Jenburkt Pharmaceuticals Ltd Logo
Jenburkt Pharmaceuticals Ltd
BSE:524731
Watchlist
Price: 1 085.8 INR -0.24%
Market Cap: 4.8B INR

Intrinsic Value

The intrinsic value of one JENBURPH stock under the Base Case scenario is 677.14 INR. Compared to the current market price of 1 085.8 INR, Jenburkt Pharmaceuticals Ltd is Overvalued by 38%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

JENBURPH Intrinsic Value
677.14 INR
Overvaluation 38%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Jenburkt Pharmaceuticals Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about JENBURPH?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is JENBURPH valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Jenburkt Pharmaceuticals Ltd.

Explain Valuation
Compare JENBURPH to

Fundamental Analysis

Jenburkt Pharmaceuticals Ltd
Company Overview
Loading...
Economic Moat
Loading...
Contacts
Loading...
How do you feel about JENBURPH?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Jenburkt Pharmaceuticals Ltd

Current Assets 453.7m
Cash & Short-Term Investments 100.2m
Receivables 233m
Other Current Assets 120.5m
Non-Current Assets 1.6B
Long-Term Investments 958.8m
PP&E 655.4m
Intangibles 3.8m
Other Non-Current Assets 19.1m
Current Liabilities 209.2m
Accounts Payable 95.4m
Accrued Liabilities 10.3m
Other Current Liabilities 103.5m
Non-Current Liabilities 52.6m
Long-Term Debt 12.7m
Other Non-Current Liabilities 40m
Efficiency

Free Cash Flow Analysis
Jenburkt Pharmaceuticals Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Jenburkt Pharmaceuticals Ltd

Revenue
1.6B INR
Cost of Revenue
-299.6m INR
Gross Profit
1.3B INR
Operating Expenses
-903.6m INR
Operating Income
387m INR
Other Expenses
-57m INR
Net Income
330m INR
Fundamental Scores

JENBURPH Profitability Score
Profitability Due Diligence

Jenburkt Pharmaceuticals Ltd's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

Positive 3Y Average ROIC
Exceptional Gross Margin
Positive 3Y Average ROE
Strong 3Y Average Gross Margin
62/100
Profitability
Score

Jenburkt Pharmaceuticals Ltd's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

JENBURPH Solvency Score
Solvency Due Diligence

Jenburkt Pharmaceuticals Ltd's solvency score is 95/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Long-Term Solvency
Negative Net Debt
95/100
Solvency
Score

Jenburkt Pharmaceuticals Ltd's solvency score is 95/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

JENBURPH Price Targets Summary
Jenburkt Pharmaceuticals Ltd

Wall Street analysts forecast JENBURPH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for JENBURPH is 1 397.4 INR with a low forecast of 1 383.7 INR and a high forecast of 1 438.5 INR.

Lowest
Price Target
1 383.7 INR
27% Upside
Average
Price Target
1 397.4 INR
29% Upside
Highest
Price Target
1 438.5 INR
32% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for JENBURPH is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one JENBURPH stock?

The intrinsic value of one JENBURPH stock under the Base Case scenario is 677.14 INR.

Is JENBURPH stock undervalued or overvalued?

Compared to the current market price of 1 085.8 INR, Jenburkt Pharmaceuticals Ltd is Overvalued by 38%.

Back to Top